Alison Cavalier

881 total citations
6 papers, 81 citations indexed

About

Alison Cavalier is a scholar working on Pharmacology, Oncology and Infectious Diseases. According to data from OpenAlex, Alison Cavalier has authored 6 papers receiving a total of 81 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Alison Cavalier's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Food Allergy and Anaphylaxis Research (1 paper). Alison Cavalier is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Food Allergy and Anaphylaxis Research (1 paper). Alison Cavalier collaborates with scholars based in France and United Kingdom. Alison Cavalier's co-authors include Raoul Herbrecht, Emmanuel Andrès, Dominique Levêque, H. Monteil, Johannes Peter, F. Jehl, Georges Kaltenbach, A. E. Johnston, Hua Xu and Frederic J. Sage and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Drugs & Aging and Chemotherapy.

In The Last Decade

Alison Cavalier

6 papers receiving 77 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Cavalier France 5 38 31 24 19 12 6 81
Valentina Isernia Spain 5 79 2.1× 30 1.0× 12 0.5× 7 0.4× 3 0.3× 10 112
Antje van der Linden New Zealand 4 40 1.1× 41 1.3× 40 1.7× 6 0.3× 29 2.4× 4 116
Amelia N. Deitchman United States 9 66 1.7× 44 1.4× 60 2.5× 12 0.6× 8 0.7× 21 171
A.P. Limaye United States 3 29 0.8× 99 3.2× 10 0.4× 33 1.7× 4 0.3× 3 131
Sara Grillo Spain 7 60 1.6× 47 1.5× 15 0.6× 14 0.7× 2 0.2× 14 118
A. Geddes United Kingdom 5 20 0.5× 42 1.4× 47 2.0× 7 0.4× 3 0.3× 7 126
Austin Morrison United States 5 67 1.8× 22 0.7× 14 0.6× 14 0.7× 2 0.2× 14 109
Fanny Alby‐Laurent France 6 17 0.4× 22 0.7× 10 0.4× 14 0.7× 4 0.3× 12 97
Yaneicy Gonzalez‐Rojas United States 2 74 1.9× 24 0.8× 21 0.9× 5 0.3× 3 0.3× 2 111
Najma Shaheen Pakistan 6 13 0.3× 28 0.9× 10 0.4× 11 0.6× 14 1.2× 29 112

Countries citing papers authored by Alison Cavalier

Since Specialization
Citations

This map shows the geographic impact of Alison Cavalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Cavalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Cavalier more than expected).

Fields of papers citing papers by Alison Cavalier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Cavalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Cavalier. The network helps show where Alison Cavalier may publish in the future.

Co-authorship network of co-authors of Alison Cavalier

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Cavalier. A scholar is included among the top collaborators of Alison Cavalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Cavalier. Alison Cavalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Odor, Peter M., Alison Cavalier, Neal Reynolds, et al.. (2019). Safety and Pharmacokinetics of Levobupivacaine Following Fascia Iliaca Compartment Block in Elderly Patients. Drugs & Aging. 36(6). 541–548. 6 indexed citations
2.
Herbrecht, Raoul, et al.. (1999). Safety and Efficacy of Amphotericin B Colloidal Dispersion. Chemotherapy. 45(Suppl. 1). 67–76. 35 indexed citations
3.
Cavalier, Alison, et al.. (1997). Pharmacokinetic interaction between itraconazole and ceftriaxone in Yucatan miniature pigs. Antimicrobial Agents and Chemotherapy. 41(9). 2029–2032. 11 indexed citations
4.
Kaltenbach, Georges, Dominique Levêque, Johannes Peter, et al.. (1996). Pharmacokinetic interaction between itraconazole and rifampin in Yucatan miniature pigs. Antimicrobial Agents and Chemotherapy. 40(9). 2043–2046. 22 indexed citations
5.
Levêque, Dominique, Johannes Peter, Georges Kaltenbach, et al.. (1996). Validation du modèle de microporc Yucatan pour les études pharmacocinétiques du ceftriaxone, céfépime, cefpirome et méropénème. Médecine et Maladies Infectieuses. 26. 599–604. 4 indexed citations
6.
Levêque, Dominique, et al.. (1996). [Model of a miniature pig catheterized for pharmacokinetic and pharmacodynamic studies of anti-infective agents].. PubMed. 44(5). 375–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026